PL3038633T3 - Stabilne polipeptydy wiążące się z ludzkim dopełniaczem c5 - Google Patents

Stabilne polipeptydy wiążące się z ludzkim dopełniaczem c5

Info

Publication number
PL3038633T3
PL3038633T3 PL14765883T PL14765883T PL3038633T3 PL 3038633 T3 PL3038633 T3 PL 3038633T3 PL 14765883 T PL14765883 T PL 14765883T PL 14765883 T PL14765883 T PL 14765883T PL 3038633 T3 PL3038633 T3 PL 3038633T3
Authority
PL
Poland
Prior art keywords
human complement
polypeptides binding
stable polypeptides
stable
binding
Prior art date
Application number
PL14765883T
Other languages
English (en)
Inventor
Joakim Nilsson
Erik Nordling
Patrik STRÖMBERG
Original Assignee
Ipc Research, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipc Research, Llc filed Critical Ipc Research, Llc
Publication of PL3038633T3 publication Critical patent/PL3038633T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
PL14765883T 2013-08-28 2014-08-28 Stabilne polipeptydy wiążące się z ludzkim dopełniaczem c5 PL3038633T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1350986 2013-08-28
PCT/EP2014/068282 WO2015028558A1 (en) 2013-08-28 2014-08-28 Stable polypeptides binding to human complement c5
EP14765883.5A EP3038633B1 (en) 2013-08-28 2014-08-28 Stable polypeptides binding to human complement c5

Publications (1)

Publication Number Publication Date
PL3038633T3 true PL3038633T3 (pl) 2021-07-19

Family

ID=51539238

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14765883T PL3038633T3 (pl) 2013-08-28 2014-08-28 Stabilne polipeptydy wiążące się z ludzkim dopełniaczem c5

Country Status (29)

Country Link
US (1) US9994626B2 (pl)
EP (2) EP3811961B1 (pl)
JP (2) JP6767865B2 (pl)
KR (1) KR102446636B1 (pl)
CN (1) CN105658228B (pl)
AU (1) AU2014314222B2 (pl)
BR (1) BR112016003142A2 (pl)
CA (1) CA2926976C (pl)
CY (1) CY1123732T1 (pl)
DK (1) DK3038633T3 (pl)
ES (1) ES2842105T3 (pl)
HR (1) HRP20210013T1 (pl)
HU (1) HUE052613T2 (pl)
IL (1) IL244218A (pl)
LT (1) LT3038633T (pl)
MX (1) MX382140B (pl)
MY (1) MY173804A (pl)
NZ (1) NZ718153A (pl)
PH (1) PH12016500371A1 (pl)
PL (1) PL3038633T3 (pl)
PT (1) PT3038633T (pl)
RS (1) RS61347B1 (pl)
RU (2) RU2733897C2 (pl)
SA (1) SA516370622B1 (pl)
SG (1) SG11201602679VA (pl)
SI (1) SI3038633T1 (pl)
SM (1) SMT202100006T1 (pl)
UA (1) UA117933C2 (pl)
WO (1) WO2015028558A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE041996T2 (hu) * 2012-02-20 2019-07-29 Swedish Orphan Biovitrum Ab Publ A C5 humán komplementhez kötõdõ polipeptidek
PL3038633T3 (pl) * 2013-08-28 2021-07-19 Ipc Research, Llc Stabilne polipeptydy wiążące się z ludzkim dopełniaczem c5
ES2742505T3 (es) 2013-08-28 2020-02-14 Affibody Ab Polipéptidos de unión que tienen un andamio mutado
UY37651A (es) * 2017-03-31 2018-10-31 Swedish Orphan Biovitrum Ab Publ Polipéptido de unión al il-1r-i
US11498960B2 (en) 2017-07-11 2022-11-15 Alexion Pharmaceuticals, Inc. Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
US20240124533A1 (en) * 2021-02-15 2024-04-18 Affibody Ab New her2-binding polypeptide
WO2023077139A1 (en) * 2021-11-01 2023-05-04 Ipc Research, Llc Administration of c5-binding proteins
WO2024227886A1 (en) 2023-05-02 2024-11-07 Mebrahtu Aman Bispecific binding molecule

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
ES2333775T3 (es) 2000-10-10 2010-03-01 Genentech, Inc. Inhibicion de la activacion del complemento c5 para el tratamiento y la prevencion de rechazo de xenoinjerto retrasado o rechazo vascular agudo.
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
WO2003015819A1 (en) * 2001-08-17 2003-02-27 Tanox, Inc. Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b
ITMI20021527A1 (it) 2002-07-11 2004-01-12 Consiglio Nazionale Ricerche Anticorpi anti componente c5 del complemento e loro uso
CA2579635A1 (en) * 2003-09-10 2005-03-17 Baxter International Inc. Peptides that inhibit complement activation
SE0400274D0 (sv) * 2004-02-09 2004-02-09 Affibody Ab New polypeptide
GB0518443D0 (en) * 2005-09-09 2005-10-19 Evolutec Ltd Method of treating myasthenia gravis
RU2477137C2 (ru) * 2006-03-08 2013-03-10 АРКЕМИКС Эл Эл Си Связывающие комплемент аптамеры и средства против с5, пригодные для лечения глазных нарушений
PL3167888T3 (pl) 2006-03-15 2024-08-26 Alexion Pharmaceuticals, Inc. Leczenie pacjentów z napadową nocną hemoglobinurią za pomocą inhibitora dopełniacza
EP2546261A3 (en) 2007-07-31 2013-08-14 Affibody AB New compositions, methods and use
US9187535B2 (en) 2007-12-19 2015-11-17 Affibody Ab Polypeptide derived from protein A and able to bind PDGF
DK2231860T3 (da) 2007-12-19 2011-12-05 Affibody Ab Polypeptid afledt protein A og i stand til at binde PDGF
EP2072525A1 (en) 2007-12-21 2009-06-24 Affibody AB New polypeptides having affinity for HER2
PY09026846A (es) 2008-08-05 2015-09-01 Novartis Ag Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5
EP2327725A1 (en) 2009-11-26 2011-06-01 InflaRx GmbH Anti-C5a binding moieties with high blocking activity
KR101884654B1 (ko) * 2010-07-09 2018-08-02 애피바디 에이비 폴리펩타이드
HUE041996T2 (hu) 2012-02-20 2019-07-29 Swedish Orphan Biovitrum Ab Publ A C5 humán komplementhez kötõdõ polipeptidek
JP5980104B2 (ja) 2012-11-22 2016-08-31 三菱電機株式会社 液晶表示装置の製造方法および液晶表示装置の製造システム
JP6577868B2 (ja) 2012-12-19 2019-09-18 アフィボディ・アーベー 新規ポリペプチド
PL3038633T3 (pl) * 2013-08-28 2021-07-19 Ipc Research, Llc Stabilne polipeptydy wiążące się z ludzkim dopełniaczem c5
ES2742505T3 (es) * 2013-08-28 2020-02-14 Affibody Ab Polipéptidos de unión que tienen un andamio mutado

Also Published As

Publication number Publication date
AU2014314222A1 (en) 2016-04-21
RS61347B1 (sr) 2021-02-26
JP2016529270A (ja) 2016-09-23
SMT202100006T1 (it) 2021-03-15
WO2015028558A1 (en) 2015-03-05
DK3038633T3 (da) 2021-01-11
PH12016500371B1 (en) 2016-05-02
CN105658228A (zh) 2016-06-08
SI3038633T1 (sl) 2021-05-31
NZ718153A (en) 2022-05-27
IL244218A0 (en) 2016-04-21
KR102446636B1 (ko) 2022-09-23
RU2016111115A (ru) 2017-10-03
HK1225656A1 (en) 2017-09-15
HRP20210013T1 (hr) 2021-04-02
RU2733897C2 (ru) 2020-10-09
UA117933C2 (uk) 2018-10-25
CN105658228B (zh) 2020-02-07
JP2020172505A (ja) 2020-10-22
IL244218A (en) 2017-11-30
HUE052613T2 (hu) 2021-05-28
ES2842105T3 (es) 2021-07-12
EP3811961A1 (en) 2021-04-28
AU2014314222B2 (en) 2018-05-24
BR112016003142A2 (pt) 2017-10-17
MX2016002397A (es) 2016-09-08
JP6767865B2 (ja) 2020-10-14
CA2926976C (en) 2023-11-28
KR20160048121A (ko) 2016-05-03
RU2016111115A3 (pl) 2018-04-25
SA516370622B1 (ar) 2018-12-23
CA2926976A1 (en) 2015-03-05
PH12016500371A1 (en) 2016-05-02
EP3038633A1 (en) 2016-07-06
EP3811961B1 (en) 2025-08-20
EP3038633B1 (en) 2020-10-14
PT3038633T (pt) 2021-01-14
US20160311870A1 (en) 2016-10-27
US9994626B2 (en) 2018-06-12
MY173804A (en) 2020-02-24
RU2020128977A (ru) 2021-11-30
CY1123732T1 (el) 2021-10-29
BR122023020080A2 (pt) 2023-12-26
LT3038633T (lt) 2021-03-25
MX382140B (es) 2025-03-13
SG11201602679VA (en) 2016-05-30

Similar Documents

Publication Publication Date Title
IL304738A (en) Polypeptides with hyperglycosidic bonds
IL267724B (en) Human c5 complement-binding polypeptides
IL240838A0 (en) Anti-3–lag binding proteins
IL244218A (en) Stable polypeptides bind to human c5 complement
SG11201604663SA (en) Cd44 binding peptides
PL2839750T3 (pl) Kompozycja tłuszczowa
PL2956010T5 (pl) Kompozycja tłuszczów
GB201310918D0 (en) Prosthesis
ZA201507808B (en) Binding element
ZA201600535B (en) Cosmetic composition
EP3007784A4 (en) SNOWBOARD
SG11201508627XA (en) Peptides binding to parallel-stranded g-quadruplexes
GB201303977D0 (en) Binding polypeptides
GB201318147D0 (en) Herbal composition
GB201318146D0 (en) Herbal composition
GB201310949D0 (en) Binding Motif
TWM475270U (en) Natural extract dressing
GB201318941D0 (en) Novel polypeptides